Recent regulatory scrutiny in Germany has cast a spotlight on misoprostol (Angusta) and its role in labour induction, raising significant safety concerns. As this conversation unfolds across Europe, healthcare professionals are re-evaluating their induction protocols and looking to non-pharmacological methods like DILAPAN-S as a safer alternative.

These 30-minute sessions are hosted by a DILAPAN-S specialist, offering an opportunity to obtain your DILAPAN-S certification.

Advice from experienced healthcare professionals on finding success with mechanical IOL methods